HIGH-DOSE-RATE BRACHYTHERAPY IN THE MANAGEMENT OF CARCINOMA OF THE CERVIX - AN 8-YEAR AUSTRALIAN EXPERIENCE

Authors
MACLEOD C FOWLER A DALRYMPLE C DCOSTA I FIRTH I ATKINSON K ELLIOT P CARTER J
Citation
C. Macleod et al., HIGH-DOSE-RATE BRACHYTHERAPY IN THE MANAGEMENT OF CARCINOMA OF THE CERVIX - AN 8-YEAR AUSTRALIAN EXPERIENCE, Australian and New Zealand Journal of Obstetrics and Gynaecology, 37(3), 1997, pp. 342-347
Citations number
16
Categorie Soggetti
Obsetric & Gynecology
Journal title
Australian and New Zealand Journal of Obstetrics and Gynaecology → ACNP
ISSN journal
00048666
Volume
37
Issue
3
Year of publication
1997
Pages
342 - 347
Database
ISI
SICI code
0004-8666(1997)37:3<342:HBITMO>2.0.ZU;2-Q
Abstract
High-dose-rate brachytherapy was introduced at this hospital for the t reatment of gynaecological malignancy in 1985. A retrospective analysi s was performed of 103 patients with cervix cancer treated with this t echnique from 1985 to June, 1993. The patients were analyzed for treat ment parameters, response, survival, relapse and toxicity. Five-year s urvival was 78% for Stage 1B, 72% for Stage 2A, 42% for Stage 2B and 2 9% for Stage 3B. The severe late toxicity rate was 4.9%. These results are similar to reported international series that have used either lo w-dose-rate or high-dose-rate brachytherapy.